← Leaderboards
Wendong Huang
Baylor College Of Medicine
$7,587,297
Attributed
$9,356,230
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,356,230 · 9
By mechanism
R01$8,444,024 · 5
R56$662,500 · 2
R03$169,000 · 1
F32$80,706 · 1
Top collaborators
- Hua E Yu5 shared
- Thomas D Y Chung1 shared
- Mingye Feng1 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- David D Moore$17,888,087
- Koen Jozef Theo Venken$2,025,968
- Amy Boriskie Hair$2,033,411
- Clavia Ruth Wooton-Kee$2,082,021
- Robert Taylor Ripley$2,243,195
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverEffective TherapyMediatingInnovationGenesInsightLeadKnockout MiceMetabolicMolecularMouse ModelBile AcidsGene ExpressionAnimal ModelNovel StrategiesInflammationPathway InteractionsTechnologyEnzymesHepatocyteIncidenceHepaticMalignant NeoplasmsLink
Grant awards (25)
Discovery and validation of CYP8B1 Inhibitors as probes for targeting Hepatocellular Carcinomas (HCC)$793,324
R01 · FY2025 · CA · contact PI
Targeting Tumor-Associated Macrophages to Treat Lymphoma$702,495
R01 · FY2025 · CA · contact PI
Targeting bile acid composition to treat metabolic diseases$599,308
R01 · FY2025 · DK · contact PI
Targeting bile acid composition to treat metabolic diseases$651,439
R01 · FY2024 · DK · contact PI
Bile acids and metabolic surgery$380,160
R01 · FY2024 · DK · contact PI
Conjugated bile acids as metabolic mediators between gut and fat tissues$222,500
R56 · FY2024 · DK · contact PI
Bile acids and metabolic surgery$396,000
R01 · FY2023 · DK · contact PI
Bile acids and metabolic surgery$396,000
R01 · FY2022 · DK · contact PI
Intestinal Regulation of Gut Microbiota and Metabolism$440,000
R56 · FY2021 · DK · contact PI
MiRNAs in hepatocellular carcinoma development and treatment$410,875
R01 · FY2021 · CA · contact PI
Bile acids and metabolic surgery$396,000
R01 · FY2021 · DK · contact PI
MiRNAs in hepatocellular carcinoma development and treatment$410,875
R01 · FY2020 · CA · contact PI
Bile acids and metabolic surgery$396,000
R01 · FY2020 · DK · contact PI
MiRNAs in hepatocellular carcinoma development and treatment$398,548
R01 · FY2019 · CA · contact PI
MiRNAs in hepatocellular carcinoma development and treatment$410,875
R01 · FY2018 · CA · contact PI
MiRNAs in hepatocellular carcinoma development and treatment$410,875
R01 · FY2017 · CA · contact PI
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR$344,450
R01 · FY2015 · CA · contact PI
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR$334,117
R01 · FY2014 · CA · contact PI
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR$323,783
R01 · FY2013 · CA · contact PI
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR$344,450
R01 · FY2012 · CA · contact PI
INVESTIGATION OF THE ROLES OF NUCLEAR RECEPTOR FXR IN HEPATOCELLULAR$344,450
R01 · FY2011 · CA · contact PI
Regulation of androgen metabolism by the nuclear receptor CAR$84,500
R03 · FY2008 · CA · contact PI
Regulation of androgen metabolism by the nuclear receptor CAR$84,500
R03 · FY2007 · CA · contact PI
Regulation of Bilirubin Metabolism by the Receptor CAR$31,778
F32 · FY2005 · DK
Regulation of Bilirubin Metabolism by the Receptor CAR$48,928
F32 · FY2004 · DK